Targeted therapy

December 16, 2021
Brielle Gregory Collins, ASCO staff

New Treatments for Non-Small Cell Lung Cancer With an EGFR Mutation: What to Know

English
Brielle.Gregory.Collins

In this podcast, 4 experts discuss the first-ever targeted therapies approved for people with non-small cell lung cancer with an epidermal growth factor receptor (EGFR) exon 20 insertion mutation, including how they work and what they mean for people with this type of cancer.

Read More >>
Subscribe to RSS - Targeted therapy